lasofoxifene
A2181037
Phase 3 small_molecule completed
Quick answer
lasofoxifene for Osteoporosis is a Phase 3 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 3 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Osteoporosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed